Prevention and treatment of FGFR inhibitor-associated toxicities
Amit Mahipal, Sri Harsha Tella, Anuhya Kommalapati, James Yu, Richard D. Kim
Topics & Concepts
Fibroblast growth factor receptorDiscontinuationMedicineTyrosine-kinase inhibitorAdverse effectClinical trialTyrosine kinaseDrugOncologyPharmacologyFibroblast growth factorInternal medicineBioinformaticsCancerReceptorBiologyFibroblast Growth Factor ResearchSoft tissue tumor case studiesKruppel-like factors research